The preliminary consolidated results for 2020 confirm the Group’s growth capacity even in the current global public health emergency. The growth is mainly attributable to the increase in sales of highly innovative solutions, to the international expansion, and to the increase of private customers.
On November 21 at the CIC Forum 2024, November 27 at the European Midcap, and December 3 at the Mid & Small in Milan
Innovation and technology for a new cell therapy supply chain.
A journey of transparent commitments, daily actions, and long-term vision
We have deep roots, developed through 35 years of history. Competence, experience and passion guide our present and push us towards the future.
